Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank29
3Y CAGR+119.0%
5Y CAGR-23.7%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+119.0%/yr
Annual compound
5Y CAGR
-23.7%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $63000.00 | -11.3% |
| 2024 | $71000.00 | -13.4% |
| 2023 | $82000.00 | +1266.7% |
| 2022 | $6000.00 | -99.0% |
| 2021 | $628000.00 | +157.4% |
| 2020 | $244000.00 | +75.5% |
| 2019 | $139000.00 | - |
| 2018 | $0.00 | - |